Diagnostics News and Research RSS Feed - Diagnostics News and Research

TGen, NAU to jointly develop quick, affordable and accurate test to diagnose Lyme disease

TGen, NAU to jointly develop quick, affordable and accurate test to diagnose Lyme disease

Focus On Lyme, an initiative sponsored by the Leadership Children's Foundation of Gilbert, Ariz., has donated $75,000 to the Translational Genomics Research Institute to support research into the development of a quick, affordable and accurate method of diagnosing Lyme disease. [More]
GE Healthcare wins 2015 North American Frost & Sullivan Market Leadership Award in Cardiology Informatics

GE Healthcare wins 2015 North American Frost & Sullivan Market Leadership Award in Cardiology Informatics

Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise. [More]
Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing. [More]
UVA partners with MITRE to develop better health data analysis tools

UVA partners with MITRE to develop better health data analysis tools

University of Virginia Health System and The MITRE Corporation are partnering to develop better health data analysis tools to help prevent patients from getting sick and improving care while reducing healthcare costs. [More]
New approach to imaging glucose uptake activity in single living cells

New approach to imaging glucose uptake activity in single living cells

Researchers at Columbia University have reported a new approach to visualize glucose uptake activity in single living cells by light microscopy with minimum disturbance. In a recent study published in Angewandte Chemie International Edition, Associate Professor of Chemistry Wei Min's team developed a new glucose analogue that can mimic the natural glucose, and imaged its uptake as energy source by living cancer cells, neurons and tissues at the single cell level. [More]
C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP). [More]
Mindray Medical announces completion of Wuhan Dragonbio acquisition

Mindray Medical announces completion of Wuhan Dragonbio acquisition

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it completed the acquisition of the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for a total cash consideration of RMB 435 million (approximately US$ 70.2 million) pursuant to the terms of the definitive agreement entered into on July 7, 2015. [More]
AESKU.DIAGNOSTICS offers new early prognostic marker for RA

AESKU.DIAGNOSTICS offers new early prognostic marker for RA

Activity and outcome scores like DAS, DAS28, SDAI or CDAI, Larsen Score, etc. are commonly used but are time consuming and not practical in the early phase of rheumatoid arthritis (RA). [More]
Abingdon Health seeks distributors for newly launched Seralite - FLC diagnostic device

Abingdon Health seeks distributors for newly launched Seralite - FLC diagnostic device

Following the commercial launch of Seralite - FLC Abingdon Health is looking to appoint distributors in order to enable as many people as possible affected by multiple myeloma (a cancer arising from plasma cells) to have access to, and benefit from its rapid diagnostic capabilities. [More]
OGT’s popular ESHG workshop free to view online

OGT’s popular ESHG workshop free to view online

Oxford Gene Technology (OGT), The Molecular Genetics Company, has made its European Human Genetics (ESHG) Conference workshop freely available to view online. [More]

Alere announces two transactions to further strengthen its core business strategy

Alere Inc., a global leader in rapid diagnostics, announced today two transactions that further strengthen the Company's focus on its core business strategy. [More]
FDA grants CLIA waiver for Alere i Strep A test

FDA grants CLIA waiver for Alere i Strep A test

Alere Inc., a global leader in rapid diagnostic tests, today announced that the U.S. Food and Drug Administration has granted CLIA waiver for the Alere i Strep A test. The test, which was cleared for marketing by the FDA in April 2015, is the first molecular platform that detects Group A Streptococcus (GAS) bacteria in 8 minutes or less. [More]
Kalorama's new report on global advanced patient monitoring market

Kalorama's new report on global advanced patient monitoring market

According to Kalorama Information, the global advanced patient monitoring market is currently worth about $31.4 billion, inclusive of devices, peripherals, software, packaged services and other applications. The market has benefited from the demand to move to a more wireless and streamlined operation both within major health facilities and in the home treatment markets. [More]
New hand-held paper machine could be used for point-of-care detection of infectious diseases, cancer

New hand-held paper machine could be used for point-of-care detection of infectious diseases, cancer

In the U.S. and other industrialized nations, testing for infectious diseases and cancer often requires expensive equipment and highly trained specialists. In countries where resources are limited, performing the same diagnostics is far more challenging. To address this disparity, scientists are developing a portable, low-cost "paper machine" for point-of-care detection of infectious diseases, genetic conditions and cancer. [More]
Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing. [More]
New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center. [More]
Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species. [More]
New non-invasive glucose monitoring device could transform lives of people with diabetes

New non-invasive glucose monitoring device could transform lives of people with diabetes

A new laser sensor that monitors blood glucose levels without penetrating the skin could transform the lives of millions of people living with diabetes. [More]
Salk professor receives Allen Distinguished Investigator award to uncover biology of Alzheimer's disease

Salk professor receives Allen Distinguished Investigator award to uncover biology of Alzheimer's disease

The Salk Institute today announced that Rusty Gage, Salk professor in the Laboratory of Genetics, has been selected as one of five recipients of the Paul G. Allen Family Foundation's Allen Distinguished Investigator (ADI) program and will be awarded $1.5 million to conduct his research. These researchers have projects aimed at uncovering the elusive biological foundations of Alzheimer's disease. [More]
Paul G. Allen Family Foundation announces ADI grants for Alzheimer's disease research

Paul G. Allen Family Foundation announces ADI grants for Alzheimer's disease research

The Paul G. Allen Family Foundation announced today the award of Allen Distinguished Investigator (ADI) grants to five teams of researchers with projects that will open new and innovative avenues of research in Alzheimer's disease by uncovering its elusive biological roots. [More]
Advertisement
Advertisement